Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 75.45K 70.9K 64.48K 121K 8.35M 123K 831K 325K 4.18M 328K 321K 13.9M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 212M 199M 181M 341M 23.5B 347M 2.34B 914M 11.77B 923M 903M 39.1B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.39%-4.42%+68.68%+118.99% 1,052B
+0.60%-0.49%+47.81%+49.72% 627B
+0.43%+0.55%+20.70%+66.20% 441B
+0.87%-4.23%+39.57%+38.52% 349B
+0.46%-3.28%+22.37%+36.48% 287B
+0.68%-3.94%-1.87%+6.73% 241B
+0.46%-0.42%+41.98%+57.46% 224B
-1.03%-4.69%-16.03%-54.22% 202B
-0.05%+3.40%+16.60%+79.84% 172B
Average +0.29%-0.70%+26.65%+44.41% 359.52B
Weighted average by Cap. +0.41%-0.63%+39.00%+63.07%

Financials

2016 2017
Net sales 54.27M 46.87M 44.05M 40.06M 75.31M 5.19B 76.55M 516M 202M 2.6B 204M 199M 8.64B 106M 91.51M 85.99M 78.2M 147M 10.13B 149M 1.01B 394M 5.07B 398M 389M 16.86B
Net income -103M -88.94M -83.58M -76.01M -143M -9.85B -145M -979M -383M -4.93B -387M -378M -16.39B -125M -108M -102M -92.42M -174M -11.97B -177M -1.19B -466M -6B -470M -460M -19.92B
Net Debt 209M 181M 170M 155M 291M 20.03B 296M 1.99B 779M 10.03B 787M 769M 33.34B 246M 212M 199M 181M 341M 23.49B 347M 2.34B 913M 11.76B 922M 902M 39.09B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock